Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: jonathan romanowsky who wrote (254)	10/12/1998 6:35:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3044

JR: Don't know that the guy is an expert. He's a reporter that is on top of interesting stories in biotech.... while he seems to focus on top-notch research and companies, if he has further expertise, I don't know it. He discussed the concept and how it would benefit clinicals and potentially keep some drugs on the market that otherwise would come off due to side-effects. The punch line was that investors wouldn't see any profit for a long time. Companies mentioned included Incyte, Millennium and GENSET. I think that the GENSET/Abbott deal was briefly mentioned, but I wasn't listening closely. Rick